Bio-Plex 200 (Allergens)

The Food and Drug Administration is forecasting the procurement of a Bio-Plex 200 multiplex system to serve as the core instrumentation platform for the xMAP Food Allergen Detection Assay, a sophisticated multiplex immunoassay capable of simultaneously detecting multiple food allergens including gluten in a single test. This acquisition is essential to replace aging equipment that has reached the end of its reliable operational life, ensuring the continuity of method development, validation, and analytical capabilities critical to public health and food safety monitoring. The system will enable high-throughput, accurate, and efficient allergen screening necessary for regulatory compliance and consumer protection. The contract opportunity is listed under NAICS code 541990 and is managed by the FDA, with program point of contact information provided through hfpacquisitions@fda.hhs.gov. The contracting officer details are pending, and no specific set-aside or place of performance has been designated at this forecasting stage. This procurement remains a priority initiative to maintain and advance the FDA’s capacity to respond to food allergen threats through cutting-edge analytical technology.